NEW YORK (GenomeWeb) – As diagnostic exome sequencing becomes more common for rare disorders, groups are starting to look at ways to boost the success rate of such tests, which has been hovering at around 25 percent. Many have turned to so-called 'medical exomes,' where coverage of disease-related genes is boosted.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.